ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

BSA Strikes Down NCI Tissue Bank Plan, Calls for Audit of caBIG

March 11, 2011

FDA Approves Afinitor Tablets For Advanced Breast Cancer

August 31, 2012

DCCP Funds 57 Percent Of Epidemiology R01a In FY 1981, Less In 1982 But Still Above The Average For All NCI

October 2, 1981

NCI Failed to Publish Two Bypass Budgets As Funds Tightened and Sequestration Set In

October 10, 2014

Choice Of Reconstruction Can Depend On Who Consults

October 29, 2010

NIH Drops Objections To Bill For Research On Environmental Causes of Breast Cancer.

May 23, 2008